1. Home
  2. EARN vs CMPX Comparison

EARN vs CMPX Comparison

Compare EARN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • CMPX
  • Stock Information
  • Founded
  • EARN 2012
  • CMPX 2014
  • Country
  • EARN United States
  • CMPX United States
  • Employees
  • EARN N/A
  • CMPX N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EARN Real Estate
  • CMPX Health Care
  • Exchange
  • EARN Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • EARN 187.6M
  • CMPX 214.6M
  • IPO Year
  • EARN 2013
  • CMPX N/A
  • Fundamental
  • Price
  • EARN $6.48
  • CMPX $2.00
  • Analyst Decision
  • EARN Hold
  • CMPX Strong Buy
  • Analyst Count
  • EARN 1
  • CMPX 4
  • Target Price
  • EARN N/A
  • CMPX $13.75
  • AVG Volume (30 Days)
  • EARN 524.2K
  • CMPX 1.8M
  • Earning Date
  • EARN 03-05-2025
  • CMPX 11-12-2024
  • Dividend Yield
  • EARN 14.79%
  • CMPX N/A
  • EPS Growth
  • EARN 277.67
  • CMPX N/A
  • EPS
  • EARN 1.02
  • CMPX N/A
  • Revenue
  • EARN N/A
  • CMPX $850,000.00
  • Revenue This Year
  • EARN N/A
  • CMPX N/A
  • Revenue Next Year
  • EARN $89.08
  • CMPX $613.39
  • P/E Ratio
  • EARN $6.33
  • CMPX N/A
  • Revenue Growth
  • EARN N/A
  • CMPX N/A
  • 52 Week Low
  • EARN $5.54
  • CMPX $0.77
  • 52 Week High
  • EARN $7.26
  • CMPX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • EARN 42.60
  • CMPX 65.48
  • Support Level
  • EARN $6.30
  • CMPX $1.43
  • Resistance Level
  • EARN $6.68
  • CMPX $2.68
  • Average True Range (ATR)
  • EARN 0.13
  • CMPX 0.24
  • MACD
  • EARN -0.02
  • CMPX 0.06
  • Stochastic Oscillator
  • EARN 32.14
  • CMPX 46.87

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

Share on Social Networks: